BriaCell Therapeutics Corp.BCTX
Price (close)
$4.32
Market cap
$37.6M
P/E
—
Revenue (TTM)
—
Net income
-$30.7M
Dividend yield
—
1-year total return
-59.7%
Net margin
—
Revenue growth
—
Debt / equity
—
What BriaCell Therapeutics Corp. does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Net income | -$4.0M | -$13.8M | -$26.8M | -$20.3M | -$4.8M | -$26.3M |
| Free cash flow | — | — | — | — | -$24.6M | — |
More on BCTX.
- BriaCell Therapeutics Corp. summary
- BriaCell Therapeutics Corp. financial statements
- BriaCell Therapeutics Corp. key metrics
- BriaCell Therapeutics Corp. health scores and style box
- BriaCell Therapeutics Corp. earnings
- BriaCell Therapeutics Corp. dividends
- BriaCell Therapeutics Corp. valuation
- BriaCell Therapeutics Corp. ownership and insiders
- BriaCell Therapeutics Corp. peers
Figures from BriaCell Therapeutics Corp.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.